½ÃÀ庸°í¼­
»óǰÄÚµå
1812399

È£Èí ¸ð´ÏÅ͸µ ±â±â ½ÃÀå

Respiratory Monitoring Devices Market

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Transparency Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 181 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

È£Èí ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - Á¶»ç ¹üÀ§

TMR Á¶»ç º¸°í¼­ '¼¼°èÀÇ È£Èí ¸ð´ÏÅ͸µ ±â±â ½ÃÀå'Àº 2025-2035³â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ÁöÇ¥¿¡ ´ëÇÑ °¡Ä¡ ÀÖ´Â ÀλçÀÌÆ®¸¦ ¾ò±â À§ÇØ °ú°Å ¹× ÇöÀçÀÇ ¼ºÀå µ¿Çâ°ú ±âȸ¸¦ ¿¬±¸ÇÕ´Ï´Ù. º» º¸°í¼­´Â 2025³âÀ» ±âÁØ ¿¬µµ, 2035³âÀ» ¿¹Ãø ¿¬µµ·Î ¼³Á¤ÇÏ¿© ¼¼°èÀÇ È£Èí ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¼öÀͰú ¿¹ÃøÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ 2025-2035³â ¼¼°èÀÇ È£Èí ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¿¬Æò±Õ ¼ºÀå·ü(CAGR%)µµ Á¦°øÇÕ´Ï´Ù.

º» º¸°í¼­´Â ±¤¹üÀ§ÇÑ Á¶»ç¸¦ °ÅÃÄ ÀÛ¼ºµÇ¾ú½À´Ï´Ù. 1Â÷ Á¶»ç¿¡¼­´Â KOL(Key Opinion Leader), ¾÷°è ¸®´õ, ÀÇ°ß Çü¼ºÀÚµé°ú ÀÎÅͺ並 ½Ç½ÃÇß½À´Ï´Ù. 2Â÷ ¿¬±¸´Â ÁÖ¿ä ¾÷üµéÀÇ Á¦Ç° ¹®Çå, ¿¬Â÷ º¸°í¼­, º¸µµ ÀÚ·á ¹× °ü·Ã ¹®¼­¸¦ ÂüÁ¶ÇÏ¿© È£Èí ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀ» ÆÄ¾ÇÇß½À´Ï´Ù.

½ÃÀå ÇöȲ
½ÃÀå ¸ÅÃâ(2024³â) 154¾ï ´Þ·¯
½ÃÀå ¸ÅÃâ(2035³â) 433¾ï ´Þ·¯
CAGR 9.9%

º» º¸°í¼­´Â ¼¼°èÀÇ È£Èí ¸ð´ÏÅ͸µ ±â±â ½ÃÀå °æÀï ±¸µµ¸¦ Á¶»çÇß½À´Ï´Ù. ¼¼°èÀÇ È£Èí ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ÁÖ¿ä ±â¾÷ÀÌ ½Äº°µÇ°í °¢ ±â¾÷Àº ´Ù¾çÇÑ ¼Ó¼ºÀ¸·Î ÇÁ·ÎÆÄÀϸµµË´Ï´Ù. ±â¾÷ °³¿ä, À繫 »óȲ, ÃÖ±Ù µ¿Çâ, SWOT µîÀÌ º» º¸°í¼­¿¡¼­ ¼Ò°³ÇÏ´Â ¼¼°èÀÇ È£Èí ¸ð´ÏÅ͸µ ±â±â ½ÃÀå Âü¿© ±â¾÷ÀÇ ¼Ó¼ºÀÔ´Ï´Ù.

¼¼°èÀÇ È£Èí ¸ð´ÏÅ͸µ ±â±â ½ÃÀå º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • ¼¼°èÀÇ È£Èí ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ºñÁî´Ï½º ±âȸ´Â ¹«¾ùÀΰ¡?
  • ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎ, ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ, ±âȸ, À§ÇùÀº ¹«¾ùÀΰ¡?
  • ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÏ´Â Áö¿ª ½ÃÀåÀº ¾îµðÀΰ¡?
  • 2035³â ¼¼°è¿¡¼­ °¡Àå ³ôÀº ¼öÀÍÀ» ¿Ã¸± °ÍÀ¸·Î ¿¹»óµÇ´Â ºÎ¹®Àº ¹«¾ùÀΰ¡?
  • ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ºÎ¹®Àº ¹«¾ùÀΰ¡?
  • ¼¼°è ½ÃÀå¿¡¼­ »ç¾÷ Àü°³ÇÏ´Â °¢ ±â¾÷ ½ÃÀå Æ÷Áö¼ÇÀº ¹«¾ùÀΰ¡?

È£Èí ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - Á¶»ç ¸ñÀû ¹× Á¶»ç ¹æ¹ý

º» Á¶»ç º¸°í¼­´Â ¼¼°èÀÇ È£Èí ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡ ´ëÇØ Á¶»ç ¹× ºÐ¼®ÇÑ º¸°í¼­ÀÔ´Ï´Ù. º» º¸°í¼­´Â ¿¬±¸ ¸ñÀû°ú ½ÃÀå ³» ÁÖ¿ä °ø±Þ¾÷ü ¹× À¯Åë¾÷ü, Á¦Ç° ½ÂÀÎÀ» À§ÇÑ ±ÔÁ¦ ȯ°æ¿¡ ´ëÇÑ »ó¼¼ÇÑ ¼³¸íÀ» Á¦°øÇÕ´Ï´Ù.

µ¶ÇØ ÆíÀǼºÀ» À§ÇØ º¸°í¼­´Â À庰 ±¸¼ºÀ¸·Î Æí¼ºµÇ¾úÀ¸¸ç, °¢ ºÎºÐÀº ¼Ò´ÜÀ§·Î ¼¼ºÐÈ­µÇ¾ú½À´Ï´Ù. º¸°í¼­´Â ÀûÀýÈ÷ ¹èÄ¡µÈ ¹æ´ëÇÑ ¾çÀÇ ±×·¡ÇÁ¿Í Ç¥·Î ±¸¼ºµË´Ï´Ù. ÁÖ¿ä ºÎ¹®ÀÇ ½ÇÁ¦ ¹× ¿¹»ó °ªÀ» ½Ã°¢ÀûÀ¸·Î Ç¥ÇöÇÑ ³»¿ëÀº µ¶ÀÚ¿¡°Ô ½Ã°¢Àû ¸Å·ÂÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ´Â ¶ÇÇÑ °ú°Å¿Í ¿¹Ãø ±â°£ ¸» ±âÁØ ÁÖ¿ä ºÎ¹®ÀÇ ½ÃÀå Á¡À¯À² ºñ±³¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.

º» º¸°í¼­´Â ¼¼°èÀÇ È£Èí ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀ» Á¦Ç°, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ªº°·Î ºÐ¼®ÇÕ´Ï´Ù. °¢ ±âÁØÀÇ ÁÖ¿ä ºÎ¹®À» »ó¼¼ÇÏ°Ô Á¶»çÇϰí 2035³â ¸» ½ÃÁ¡ÀÇ °¢ ºÎ¹®¿¡ ´ëÇÑ ½ÃÀå Á¡À¯À²À» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °¡Ä¡ ÀÖ´Â ÀλçÀÌÆ®´Â ½ÃÀå °ü°èÀÚµéÀÌ ¼¼°èÀÇ È£Èí ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡ ´ëÇÑ ÅõÀÚ¿¡ ´ëÇÑ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ºñÁî´Ï½º ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÀüÁ¦Á¶°Ç°ú Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à : ¼¼°è ½ÃÀå

Á¦4Àå ½ÃÀå °³¿ä

  • ¼Ò°³
  • °³¿ä
  • ½ÃÀå ¿ªÇÐ
  • ¼¼°èÀÇ È£Èí ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ºÐ¼®°ú ¿¹Ãø(2020-2035³â)

Á¦5Àå ÁÖ¿ä ÀλçÀÌÆ®

  • ±â¼úÀû Áøº¸
  • Porter's Five Forces ºÐ¼®
  • ÁÖ¿ä »ê¾÷ À̺¥Æ®
  • PESTEL ºÐ¼®
  • ¹ë·ùüÀÎ ºÐ¼®
  • ÁÖ¿ä ¾÷°è À̺¥Æ®(ÇÕº´, Àμö, Á¦ÈÞ, Çù¾÷ µî)
  • °¡°Ý ºÐ¼®(ºê·£µå °¡°Ý, Áö¿ª ¹× ±¹°¡º° Æò±Õ ÆÇ¸Å °¡°Ý)
  • ¿¬±¸°³¹ß µ¿Çâ
  • ½Å±Ô ½ÃÀå Âü°¡ÀÚ¸¦ À§ÇÑ ½ÃÀå °³Ã´ Àü·«

Á¦6Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ±â±â À¯Çüº°

  • ¼Ò°³ ¹× Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú ¹× ¹ßÀü
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : ±â±â À¯Çüº°(2020-2035³â)
    • ½ºÆÄÀ̷ιÌÅÍ
    • »ê¼ÒÆ÷È­µµ ÃøÁ¤±â
    • Ä«ÇÁ³ë±×·¡ÇÁ
    • ¹«È£Èí ¸ð´ÏÅÍ
    • È£±â ÀÏ»êÈ­Áú¼Ò ¸ð´ÏÅÍ
    • ±âŸ
  • ½ÃÀå ¸Å·Â ºÐ¼® : ±â±â À¯Çüº°

Á¦7Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ¿ëµµº°

  • ¼Ò°³ ¹× Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú ¹× ¹ßÀü
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : ¿ëµµº°(2020-2035³â)
    • ¼ö¸é ¹«È£ÈíÁõÈıº
    • COPD
    • õ½Ä
    • ±Þ¼º È£Èí °ï¶õ ÁõÈıº(ARDS)
    • Æó°íÇ÷¾Ð
    • ±âŸ
  • ½ÃÀå ¸Å·Â ºÐ¼® : ¿ëµµº°

Á¦8Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼Ò°³ ¹× Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú ¹× ¹ßÀü
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : ÃÖÁ¾ »ç¿ëÀÚº°(2020-2035³â)
    • º´¿ø ¹× Áø·á¼Ò
    • ÀçÅÃÄ¡·á
    • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
    • ±âŸ
  • ½ÃÀå ¸Å·Â ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦9Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : Áö¿ªº°(2020-2035³â)
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀå ¸Å·Â ºÐ¼® : Áö¿ªº°

Á¦10Àå ºÏ¹Ì ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦11Àå À¯·´ ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦13Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦14Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå ±â¾÷ : °æÀï ¸ÅÆ®¸¯½º(±â¾÷ µî±Þº°, ±Ô¸ðº°)
  • ½ÃÀå Á¡À¯À² ºÐ¼® : ±â¾÷º°(2024³â)
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Medtronic
    • CONTEC MEDICAL SYSTEMS CO.,LTD
    • SIBELMED
    • Clarity
    • GE Healthcare
    • Masimo
    • Philips Healthcare
    • MGC Diagnostics Corporation
    • Dragerwerk AG & Co. KGaA
    • Narang Medical Limited
HBR 25.09.29

Respiratory Monitoring Devices Market- Scope of Report

TMR's report on the global Respiratory Monitoring Devices Marketstudies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Respiratory Monitoring Devices Marketfor the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Respiratory Monitoring Devices Marketfrom 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Respiratory Monitoring Devices Market .

Market Snapshot
Market Value in 2024US$ 15.4 Bn
Market Value in 2035US$ 43.3 Bn
CAGR9.9%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Respiratory Monitoring Devices Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Respiratory Monitoring Devices Market . These serve as valuable tools for existing Market players as well as for entities interested in participating in the global Respiratory Monitoring Devices Market .

The report delves into the competitive landscape of the global Respiratory Monitoring Devices Market . Key players operating in the global Respiratory Monitoring Devices Markethave been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Respiratory Monitoring Devices Marketprofiled in this report.

Key Questions Answered in Global Respiratory Monitoring Devices MarketReport:

  • What are the opportunities in the global Respiratory Monitoring Devices Market ?
  • What are the major drivers, restraints, opportunities, and threats in the Market ?
  • Which regional Market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the Market positions of different companies operating in the global Market ?

Respiratory Monitoring Devices Market- Research Objectives and Research Approach

The comprehensive report on the global Respiratory Monitoring Devices Marketbegins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Respiratory Monitoring Devices Marketin terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the global Respiratory Monitoring Devices Market .

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Respiratory Monitoring Devices Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Respiratory Monitoring Devices Market Analysis and Forecast, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. PORTER's Five Forces Analysis
  • 5.3. Key Industry Events
  • 5.4. PESTEL Analysis
  • 5.5. Value Chain Analysis
  • 5.6. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
  • 5.7. Pricing Analysis (Brand pricing, Average Selling Price by Region/Country)
  • 5.8. Research and Development Trends
  • 5.9. Go-to-Market Strategy for New Market Entrants

6. Global Respiratory Monitoring Devices Market Analysis and Forecast, by Device Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Device Type, 2020 to 2035
    • 6.3.1. Spirometers
    • 6.3.2. Pulse Oximeters
    • 6.3.3. Capnographs
    • 6.3.4. Apnea Monitor
    • 6.3.5. Exhaled Nitric Oxide Monitor
    • 6.3.6. Others
  • 6.4. Market Attractiveness Analysis, by Device Type

7. Global Respiratory Monitoring Devices Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2020 to 2035
    • 7.3.1. Sleep Apnea
    • 7.3.2. COPD
    • 7.3.3. Asthma
    • 7.3.4. Acute Respiratory Distress Syndrome (ARDS)
    • 7.3.5. Pulmonary Hypertension
    • 7.3.6. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Respiratory Monitoring Devices Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2020 to 2035
    • 8.3.1. Hospitals & Clinics
    • 8.3.2. Home-care Settings
    • 8.3.3. Ambulatory Surgical Centers
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Respiratory Monitoring Devices Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020 to 2035
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Respiratory Monitoring Devices Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Device Type, 2020 to 2035
    • 10.2.1. Spirometers
    • 10.2.2. Pulse Oximeters
    • 10.2.3. Capnographs
    • 10.2.4. Apnea Monitor
    • 10.2.5. Exhaled Nitric Oxide Monitor
    • 10.2.6. Others
  • 10.3. Market Value Forecast, by Application, 2020 to 2035
    • 10.3.1. Sleep Apnea
    • 10.3.2. COPD
    • 10.3.3. Asthma
    • 10.3.4. Acute Respiratory Distress Syndrome (ARDS)
    • 10.3.5. Pulmonary Hypertension
    • 10.3.6. Others
  • 10.4. Market Value Forecast, by End-user, 2020 to 2035
    • 10.4.1. Hospitals & Clinics
    • 10.4.2. Home-care Settings
    • 10.4.3. Ambulatory Surgical Centers
    • 10.4.4. Others
  • 10.5. Market Value Forecast, by Country, 2020 to 2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Device Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Respiratory Monitoring Devices Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Device Type, 2020 to 2035
    • 11.2.1. Spirometers
    • 11.2.2. Pulse Oximeters
    • 11.2.3. Capnographs
    • 11.2.4. Apnea Monitor
    • 11.2.5. Exhaled Nitric Oxide Monitor
    • 11.2.6. Others
  • 11.3. Market Value Forecast, by Application, 2020 to 2035
    • 11.3.1. Sleep Apnea
    • 11.3.2. COPD
    • 11.3.3. Asthma
    • 11.3.4. Acute Respiratory Distress Syndrome (ARDS)
    • 11.3.5. Pulmonary Hypertension
    • 11.3.6. Others
  • 11.4. Market Value Forecast, by End-user, 2020 to 2035
    • 11.4.1. Hospitals & Clinics
    • 11.4.2. Home-care Settings
    • 11.4.3. Ambulatory Surgical Centers
    • 11.4.4. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 11.5.1. Germany
    • 11.5.2. UK
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Switzerland
    • 11.5.7. The Netherlands
    • 11.5.8. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Device Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Respiratory Monitoring Devices Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Device Type, 2020 to 2035
    • 12.2.1. Spirometers
    • 12.2.2. Pulse Oximeters
    • 12.2.3. Capnographs
    • 12.2.4. Apnea Monitor
    • 12.2.5. Exhaled Nitric Oxide Monitor
    • 12.2.6. Others
  • 12.3. Market Value Forecast, by Application, 2020 to 2035
    • 12.3.1. Sleep Apnea
    • 12.3.2. COPD
    • 12.3.3. Asthma
    • 12.3.4. Acute Respiratory Distress Syndrome (ARDS)
    • 12.3.5. Pulmonary Hypertension
    • 12.3.6. Others
  • 12.4. Market Value Forecast, by End-user, 2020 to 2035
    • 12.4.1. Hospitals & Clinics
    • 12.4.2. Home-care Settings
    • 12.4.3. Ambulatory Surgical Centers
    • 12.4.4. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. South Korea
    • 12.5.5. Australia & New Zealand
    • 12.5.6. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Device Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Respiratory Monitoring Devices Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Device Type, 2020 to 2035
    • 13.2.1. Spirometers
    • 13.2.2. Pulse Oximeters
    • 13.2.3. Capnographs
    • 13.2.4. Apnea Monitor
    • 13.2.5. Exhaled Nitric Oxide Monitor
    • 13.2.6. Others
  • 13.3. Market Value Forecast, by Application, 2020 to 2035
    • 13.3.1. Sleep Apnea
    • 13.3.2. COPD
    • 13.3.3. Asthma
    • 13.3.4. Acute Respiratory Distress Syndrome (ARDS)
    • 13.3.5. Pulmonary Hypertension
    • 13.3.6. Others
  • 13.4. Market Value Forecast, by End-user, 2020 to 2035
    • 13.4.1. Hospitals & Clinics
    • 13.4.2. Home-care Settings
    • 13.4.3. Ambulatory Surgical Centers
    • 13.4.4. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Argentina
    • 13.5.4. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Device Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Respiratory Monitoring Devices Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Device Type, 2020 to 2035
    • 14.2.1. Spirometers
    • 14.2.2. Pulse Oximeters
    • 14.2.3. Capnographs
    • 14.2.4. Apnea Monitor
    • 14.2.5. Exhaled Nitric Oxide Monitor
    • 14.2.6. Others
  • 14.3. Market Value Forecast, by Application, 2020 to 2035
    • 14.3.1. Sleep Apnea
    • 14.3.2. COPD
    • 14.3.3. Asthma
    • 14.3.4. Acute Respiratory Distress Syndrome (ARDS)
    • 14.3.5. Pulmonary Hypertension
    • 14.3.6. Others
  • 14.4. Market Value Forecast, by End-user, 2020 to 2035
    • 14.4.1. Hospitals & Clinics
    • 14.4.2. Home-care Settings
    • 14.4.3. Ambulatory Surgical Centers
    • 14.4.4. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Device Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. Medtronic
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. CONTEC MEDICAL SYSTEMS CO.,LTD
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. SIBELMED
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Clarity
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. GE Healthcare
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Masimo
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Philips Healthcare
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. MGC Diagnostics Corporation
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Dragerwerk AG & Co. KGaA
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Narang Medical Limited
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦